UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.417

Sortiert nach

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1

Gene therapy, 2011-02, Vol.18 (2), p.164-172

2011

Volltextzugriff (PDF)

Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Oncogene, 2011-01, Vol.30 (3), p.323-333

2011

Volltextzugriff (PDF)

Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells

British journal of cancer, 2014-04, Vol.110 (8), p.1992-1999

2014

Volltextzugriff (PDF)

Combining immune cell and viral therapy for the treatment of cancer

Cellular and molecular life sciences : CMLS, 2007-06, Vol.64 (12), p.1449-1451, Article 1449

2007

Volltextzugriff (PDF)

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

British journal of cancer, 2015-09, Vol.113 (5), p.747-755

2015

Volltextzugriff (PDF)

Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF

Molecular therapy, 2006-09, Vol.14 (3), p.361-370

2006

Volltextzugriff (PDF)

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination

Gene therapy, 2013-07, Vol.20 (7), p.770-778

2013

Volltextzugriff (PDF)

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery

Gene therapy, 2008-05, Vol.15 (10), p.753-758

2008

Volltextzugriff (PDF)

Adaptation to nutrient starvation in Rhizobium leguminosarum bv. phaseoli: analysis of survival, stress resistance, and changes in macromolecular synthesis during entry to and exit from stationary phase

Journal of Bacteriology, 1997-11, Vol.179 (22), p.6894-6901

1997

Volltextzugriff (PDF)

Cell density-dependent starvation survival of Rhizobium leguminosarum bv. phaseoli: identification of the role of an N-acyl homoserine lactone in adaptation to stationary-phase survival

Journal of bacteriology, 1999-02, Vol.181 (3), p.981-990

1999

Volltextzugriff (PDF)

Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

Science (American Association for the Advancement of Science), 2006-03, Vol.311 (5768), p.1780-1784

2006

Volltextzugriff (PDF)

CTL- vs T sub(reg) lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

British journal of cancer, 2015-09, Vol.113 (5), p.747-755

2015

Volltextzugriff (PDF)

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer

Journal of immunotherapy (1997), 2011-04, Vol.34 (3), p.289

2011

Volltextzugriff (PDF)

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Neoplasia (New York, N.Y.), 2012-12, Vol.14 (12), p.1115-IN1

2012

Volltextzugriff (PDF)

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery: Cellular Vehicles for Gene Therapy

Gene therapy, 2008, Vol.15 (10), p.753-758

2008

Volltextzugriff (PDF)

Sustained inhibition of PKC[alpha] reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Oncogene, 2011-01, Vol.30 (3), p.323

2011

Volltextzugriff (PDF)

Ethyl pyruvate administration inhibits hepatic tumor growth

Journal of leukocyte biology, 2009-09, Vol.86 (3), p.599-607

2009

Volltextzugriff (PDF)

Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study

Clinical cancer research, 2006-03, Vol.12 (6), p.1859-1867

2006

Volltextzugriff (PDF)

Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects

Seminars in oncology, 2005-12, Vol.32 (6), p.537-548

2005

Volltextzugriff (PDF)

Using in Vivo Bioluminescence Imaging to Shed Light on Cancer Biology

Proceedings of the IEEE, 2005-04, Vol.93 (4), p.750-762

2005

Volltextzugriff (PDF)

New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution

Molecular cancer therapeutics, 2006-01, Vol.5 (1), p.97-103

2006

Volltextzugriff (PDF)

A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.15044-15044

2006

Volltextzugriff (PDF)

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Expert opinion on biological therapy, 2004-08, Vol.4 (8), p.1307-1321

2004

Volltextzugriff (PDF)

Cellular immunotherapy redirected by bispecific antibodies in primary ovarian cancer cells: A preclinical study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2518-2518

2006

Volltextzugriff (PDF)

Consensus guidelines for the detection of immunogenic cell death

Oncoimmunology, 2014-10, Vol.3 (9), p.e955691

2014

Volltextzugriff (PDF)

1 – 25 von 2.417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.068)
Mit Volltextzugriff
(2.097)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(1.040)
MEDLINE
(1.006)
Ingenta
(940)
Lippincott E Journal Collection
(656)
Publisher website
(581)
IngentaConnect Journals
(461)
Access via ScienceDirect (Elsevier)
(453)
Wiley-Blackwell Full Collection
(330)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(294)
JSTOR
(291)
Wiley Online Library Full Collection 2018
(225)
Oxford Journals
(148)
Springer journals
(124)
APS Journals (American Physical Society)
(119)
PROLA
(115)
Taylor & Francis Online
(89)
Oxford Journals 2020 Medicine
(87)
Springer Nature - Connect here FIRST to enable access
(85)
Taylor & Francis
(82)
Access via Taylor & Francis
(73)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1

Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells

Combining immune cell and viral therapy for the treatment of cancer

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF

Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery

Adaptation to nutrient starvation in Rhizobium leguminosarum bv. phaseoli: analysis of survival, stress resistance, and changes in macromolecular synthesis during entry to and exit from stationary phase

Cell density-dependent starvation survival of Rhizobium leguminosarum bv. phaseoli: identification of the role of an N-acyl homoserine lactone in adaptation to stationary-phase survival

Synergistic Antitumor Effects of Immune Cell-Viral Biotherapy

CTL- vs T sub(reg) lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery: Cellular Vehicles for Gene Therapy

Sustained inhibition of PKC[alpha] reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

Ethyl pyruvate administration inhibits hepatic tumor growth

Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study

Oncolytic Virotherapy: Approaches to Tumor Targeting and Enhancing Antitumor Effects

Using in Vivo Bioluminescence Imaging to Shed Light on Cancer Biology

New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution

A preclinical study of cellular immunotherapy redirected by bispecific antibodies in uterine cell lines and primary cancer cells

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Cellular immunotherapy redirected by bispecific antibodies in primary ovarian cancer cells: A preclinical study

Consensus guidelines for the detection of immunogenic cell death

Suchergebnisse filtern